Inflammation, Disease, and Science Behind an Anti-Inflammatory Diet
Wellness and nutrition experts Lauren Ball, and Emily Burch point out, there is a lot of health buzz around the term “inflammation” right now….
Wellness and nutrition experts Lauren Ball, and Emily Burch point out, there is a lot of health buzz around the term “inflammation” right now….
One of the largest genetic studies to date revealed extensive genetic links between Alzheimer’s and gut disorders. Cholesterol was a major factor in both….
Experts emphasize that living a healthy lifestyle can help boost brain health and reduce chances of developing dementia. Diet is one among several key…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
Áine Kelly, professor in physiology at the Trinity College Dublin, shares insights on the benefits of exercise for our memory, blood vessels and immune…
As research into COVID-19 continues, mounting evidence suggests that the disease may cause significant brain damage in some recovered patients. Some researchers have focused…
Dr. Susan White and her genetics team treated two triplets from a family who had an undiagnosed neurodegenerative disorder in 2014. After one year…
Aspirin is ineffective in reducing the risk of Alzheimer’s, according to a new study. While aspirin is one of the most widely used treatments…
Inflammation in the brain is linked to a wider range of dementia than researchers had previously thought, according to a new study. The latest…
More researchers are paying attention to the therapeutic benefits of psychedelics when it comes to treating mental illnesses like depression and addiction — and…
We’ve all seen the movie: tons of hand-to-hand combat, enemy soldiers lurking behind every wall. Now place that movie in your bloodstream and imagine…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…
As research into Alzheimer’s advances, scientists are shifting their focus from beta-amyloid accumulation to inflammation as a main driver of the disease. In a…
In 2015, drug manufacturer Pfizer discovered that their drug Enbrel (etanercept), an anti-inflammatory used to treat rheumatoid arthritis, appeared to lower the risk of…